preclinical white papers and articles

  1. Mastering The Complexities Of Targeted Medicines 8/30/2024

    Explore the challenges and strategies involved in developing targeted medicines, with insights into the complexities, collaborations, and considerations necessary for success.

  2. When Transcriptomics Meets Drug Repurposing 8/29/2024

    To support drug repurposing, transcriptomics is being used, which involves studying RNA molecules in cells to understand gene expression and identify potential drug targets.

  3. Maximizing Efficiency In Translational Medicine With An On-Site Pharmacy 7/30/2024

    Having the capability to modify the early stages of drug development in real time, based upon observed clinical and pharmacokinetic data, is crucial and can be effectively managed with an on-site pharmacy.

  4. Unveiling The Potential Of Psychedelic Therapies 7/30/2024

    Leading experts highlight the transformative potential of the rapidly evolving field of psychedelic therapies and underscore the importance of rigorous clinical trials and regulatory compliance.

  5. Essential Laboratory Services For Vaccine Trials 7/29/2024

    Testing vaccines is a rigorous but essential multi-stage process. From initial lab research to human trials and regulatory approval, discover how vaccines undergo scrutiny to protect public health.

  6. Altasciences' Facilities Moving In Unison 2/20/2024

    With nine facilities across North America, explore our integrated, comprehensive solution for all your early-phase drug development needs and unique expertise.

  7. Navigating The FDA's Draft Guidance On Psychedelic Drug Development 11/2/2023

    Uncover new guidance for the development of innovative therapies in the realm of mental health and addiction treatment.

  8. Psychedelics As Therapeutics – What Developers Need To Know 10/29/2023

    Drug developers and others intrigued by the dynamic and promising field of psychedelics as therapeutics can gain valuable guidance from a recap of the 3rd annual Psychedelic Therapeutic and Drug Development Conference.

  9. The Criticality Of CMO Selection For Small Biopharma Companies 10/29/2023

    Delve into the criteria that small or early-stage biopharma companies should consider during their CMO selection process, along with key considerations to keep in mind.

  10. Raw Materials Control For Biotechs (Part 1) 10/23/2023

    Navigate challenges posed by raw material usage and learn how to lay a robust current Good Manufacturing Practices groundwork for a control program.